Evidence map›Paper›PMID 39752095›Full record

ArticleFood and environmental virology2025

Inactivation Effects of Hypochlorous Acid, Chlorine Dioxide, and Ozone on Airborne SARS-CoV-2 and Influenza A Virus.

Yasuo Imoto, Hidehito Matsui, Chihiro Ueda, Eri Nakajima, Hideaki Hanaki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food and environmental virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yasuo Imoto *Kobe Testing Center, The Japan Textile Products Quality and Technology Center, 5-7-3 Yamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Hidehito Matsui *Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane, Minato-Ku, Tokyo, 108-8641, Japan.
Chihiro UedaKobe Testing Center, The Japan Textile Products Quality and Technology Center, 5-7-3 Yamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Eri NakajimaKobe Testing Center, The Japan Textile Products Quality and Technology Center, 5-7-3 Yamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Hideaki HanakiŌmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane, Minato-Ku, Tokyo, 108-8641, Japan. hanaki@insti.kitasato-u.ac.jp.

Funding

research on emerging and re-emerging infectious diseases and immunization 21HA2017
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus are primarily transmitted through droplets or aerosols from patients. The inactivation effects of existing virus control techniques may vary depending on the environmental factors. Therefore, it is important to establish a suitable evaluation system for assessing virus control techniques against airborne viruses for further real-world implementation. This study aimed to assess the inactivating effects of chemical substances on SARS-CoV-2 and influenza A virus in the air using an established evaluation system. A mixture containing SARS-CoV-2 and influenza A virus in diluted saliva was nebulized into the designed 1 m

Indexed as

Chlorine CompoundsDisinfectantsHypochlorous AcidInfluenza A virusOxidesOzoneSARS-CoV-2Virus InactivationAir MicrobiologyCOVID-19HumansInfluenza, HumanChlorine Compoundschlorine dioxideDisinfectantsHypochlorous AcidOxidesOzoneAirChlorine dioxideHypochlorous acidInfluenza A virusOzoneSARS-CoV-2

Identifiers

PMID39752095
PMCPMC11698893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.